Clinical Trial - Trial jRCT1030220517
Access comprehensive clinical trial information for jRCT1030220517 through Pure Global AI's free database. This phase not specified trial is sponsored by AstraZeneca K.K. and is currently Recruitment Completed. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT1030220517
Recruitment Completed
Trial Details
Japan Registry Clinical Trial • jRCT1030220517
Untitled Trial
Japanese Patient and Physician Preferences for Systemic Therapy Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Discrete Choice Experiment (SANGO HCC)
Study Focus
Observational
Sponsor & Location
AstraZeneca K.K.
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure
Data Source
Japan Registry Clinical Trial
jRCT1030220517
Non-Device Trial